Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
    Datensatz exportieren als...
  • BibTeX
Santaris Pharma A/S and miRagen Therapeutics Inc. expand worldwide strategic alliance to discover and develop LNA-drugs against disease causing microRNAs
PR Newswire, 2013
2013
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Antisense RNAi Therapeutics Market Driven By Rising Use Of Antisense Technology For Disease Management Till 2025: Grand View Research, Inc
M2 Presswire, 2018
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Kanazawa University Research: Scientists at Kanazawa University Have Unravelled a Link Between Inflammation and Cancer
PR Newswire, 2018
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets
PR Newswire, 2017
2017
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Santaris Pharma A/S Forms Strategic Alliance With Shire plc to Develop RNA-Based Medicines for the Treatment of Rare Genetic Disorders
PR Newswire, 2009
2009
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Deep Genomics Introduces the Most Advanced AI Foundation Model for RNA Disease Mechanisms and Candidate Therapeutics
Business Wire, 2023
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Regulus Therapeutics to Host Virtual Investor Event on September 6, 2023
PR Newswire, 2023
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Santaris Pharma A/S Announces Expanded Worldwide Strategic Alliance With Pfizer Inc. Directed to Development of RNA-targeted Medicines
PR Newswire, 2011
2011
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Regulus Therapeutics Reports First Quarter 2024 Financial Results and Recent Updates
PR Newswire, 2024
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Regulus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Updates
PR Newswire, 2024
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Regulus Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Updates
PR Newswire, 2023
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Regulus Therapeutics Reports Third Quarter 2023 Financial Results and Recent Updates
PR Newswire, 2023
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Regulus Therapeutics Reports Second Quarter 2023 Financial Results and Recent Updates
PR Newswire, 2023
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
BIORCHESTRA Participating in Two Upcoming Therapeutic RNA-Focused Events
PR Newswire, 2023
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
In Situ Hybridization Market Size Worth $2.6 Billion by 2028: Grand View Research, Inc
PR Newswire, 2022
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Illumina Introduces Genome-Wide DNA Methylation Profiling Using Highly Acclaimed Infinium(R) Assay
Business Wire, 2007
2007
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Johnson Johnson Symposium Honors 2012 Recipients of the Dr. Paul Janssen Award for Biomedical Research: Dr. Victor Ambros and Dr. Gary Ruvkun Honored for Discovery of microRNAs; Symposium Celebrates the Power of Science to Change the World
PR Newswire, 2012
2012
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
mRNA Therapeutics Market Size Worth $37.76 Billion by 2030: Grand View Research, Inc
PR Newswire, 2022
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Ponce Therapeutics Executes Worldwide Exclusive License to Speratum Biopharma's Nano-in™ and No-Pass Mimic™ Nanoparticle Technologies in Anti-Aging and Other Products Initially for Skin
PR Newswire, 2022
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Regulus Therapeutics Reports First Quarter 2022 Financial Results and Recent Updates
PR Newswire, 2022
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Regulus Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Updates: Successfully completed Pre-IND meeting with FDA for Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program
PR Newswire, 2022
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Marligen Exclusively Licenses Genisphere Labeling Technology for the Detection of microRNAs on the xMAP(R) Platform
Business Wire, 2008
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
PennyStockChaser.com: MDRNA, Inc. (NASDAQ: MRNA) Hot Stock on the Move
M2 Presswire, 2009
2009
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Regulus Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Recent Updates: Completed Enrollment in First Cohort of Phase 1b Clinical Trial of RGLS4326 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease ("ADPKD")
PR Newswire, 2021
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
InteRNA Technologies Establishes Clinical Advisory Board and Appoints New Members to Scientific Advisory Board
Business Wire, 2021
2021
Volltextzugriff (PDF)
1 – 25 von 293
Suche als RSS-Feed
Aktive Filter
KollektionSpringer Nature - Complete Springer Journals
KollektionWiley Online Library Full Collection 2018
Zeitschrift / SerieOncology Letters
PublikationsformTagungsberichte
PublikationsformNewsletter-Artikel
ThemaResearch & Development
Suchergebnisse filtern
Filter anzeigen